Roxyfoli 50 Syrup contains Roxithromycin 50mg, a macrolide antibiotic formulated to treat respiratory infections, pharyngitis, tonsillitis, and mild skin infections. It provides effective bacterial control and symptom relief in a patient-friendly syrup form.
Roxithromycin inhibits bacterial protein synthesis, ensuring rapid infection management while being gentle on children and adults. Syrup formulation allows easy dosing, palatability, and improved compliance, particularly in pediatric patients.
Roxyfoli 50 Syrup is widely recommended in clinics, hospitals, and pharmacies as a high-demand anti-infective therapy.
Adding Roxyfoli 50 Syrup to your anti-infective portfolio strengthens your offerings with a clinically trusted, fast-moving product. Its prescriber confidence, pediatric suitability, and export potential make it ideal for PCD pharma companies, distributors, and third-party manufacturing partners.